Skip to content

Clinical trials

Phase 3 Dilatation, Pathologic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dilatation, Pathologic Phase: Phase 3 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20141
20161
20181
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ocuphire Pharma, Inc.3
Topcon Medical Systems, Inc.2
Center for Sight, Sacramento, CA1
Crowd Health Research, LTD1
Glaukos Corporation1
Icahn School of Medicine at Mount Sinai1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dilatation, Pathologic10
Keratoconus4
Mydriasis3
Corneal Diseases2
Abortion, Missed1
Abortion, Spontaneous1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.